Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
Clinical trial NCT03063762 · COMPLETED
Trial details
- NCT number
- NCT03063762
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2021-06-14
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.